Wagner M. Zago
Chief Tech/Sci/R&D Officer bei PROTHENA CORPORATION PLC
Profil
Wagner M.
Zago is currently the Chief Scientific Officer at Prothena Corp.
Plc since 2017.
Prior to this, he worked as a Scientist at Elan Pharmaceuticals LLC from 2006 to 2012.
Dr. Zago completed his graduate and doctorate degrees at the University of Sao Paulo and his undergraduate degree at Universidade Federal De Sao Paulo.
Aktive Positionen von Wagner M. Zago
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTHENA CORPORATION PLC | Chief Tech/Sci/R&D Officer | 01.01.2015 |
Ehemalige bekannte Positionen von Wagner M. Zago
| Unternehmen | Position | Ende |
|---|---|---|
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 02.01.2012 |
Ausbildung von Wagner M. Zago
| University of Sao Paulo | Doctorate Degree |
| Universidade Federal De Sao Paulo | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
